Skip to main content

Table 1 Clinical and baseline hormonal features

From: First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?

  Non OCP group OCP group p-value
Number n = 57 n = 45  
Age (years) 30 [23.9-35.0] 28 [22.0-35.6] NS
BMI (kg/m2) 23 [18.5-33.1] 23 [18.4-32.8] NS
AFC (n) 38 [25.9-74.3] 38 [26.4-83.0] NS
Testosterone (ng/mL) 0.37 [0.18-0.81] 0.37 [0.13-0.77] NS
Δ4 androstenedione (ng/mL) 1.76 [0.89-2.83] 1.84 [0.80-3.01] NS
FSH (IU/L) 6.2 [3.7-8.9] 5.9 [3.9-8.2] NS
AMH (pmol/mL) 52.2 [18.2-132.5] 57.2 [14.9-138.9] NS
PCOS 52.6% (n = 30) 66.7% (n = 30) NS
IVF/ICSI indications     -male infertility: 66%     -male infertility: 69% NS
    -tubal infertility: 16%     -tubal infertility:11%
    -ovulation induction failure: 18%     -ovulation induction failure: 20%
ICSI 66.7% (n = 38) 68.8% (n = 31) NS
  1. NS Non significant, BMI body mass index, AFC antral follicle count, AMH antimullerian hormone, PCOS polycystic ovary syndrome (diagnostic criteria. Rotterdam 2004), ICSI intracytoplasmic sperm injection.
  2. Quantitative data presented are medians [5th – 95th percentiles].